{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:58:35Z","timestamp":1789725515476,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2542,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.virol.2006.04.003","type":"journal-article","created":{"date-parts":[[2006,5,20]],"date-time":"2006-05-20T07:22:17Z","timestamp":1148109737000},"page":"432-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Production and characterization of vaccines based on flaviviruses defective in replication"],"prefix":"10.1016","volume":"351","author":[{"given":"Peter W.","family":"Mason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr V.","family":"Shustov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Frolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2006.04.003_bib1","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.4049\/jimmunol.163.12.6756","article-title":"A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms","volume":"163","author":"Aberle","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2006.04.003_bib2","doi-asserted-by":"crossref","first-page":"15107","DOI":"10.1128\/JVI.79.24.15107-15113.2005","article-title":"Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus","volume":"79","author":"Aberle","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/vir.0.18860-0","article-title":"A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication","volume":"84","author":"Bredenbeek","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib4","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/viro.1998.9357","article-title":"DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus","volume":"250","author":"Colombage","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.04.003_bib6","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib7","unstructured":"Fayzulin, R., Scholle, F., Petrakova, O., Frolov, I., Mason, P.W., in press. Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines. Virology."},{"key":"10.1016\/j.virol.2006.04.003_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0264-410X(94)90206-2","article-title":"Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice","volume":"12","author":"Fonseca","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2006.04.003_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4269\/ajtmh.1982.31.548","article-title":"Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies","volume":"31","author":"Gentry","year":"1982","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2006.04.003_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.SMJ.0000157537.11806.DC","article-title":"Rare case of fatal yellow fever vaccine-associated viscerotropic disease","volume":"98","author":"Gerasimon","year":"2005","journal-title":"South. Med. J."},{"key":"10.1016\/j.virol.2006.04.003_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0960-9822(02)00482-7","article-title":"Codon usage limitation in the expression of HIV-1 envelope glycoprotein","volume":"6","author":"Haas","year":"1996","journal-title":"Curr. Biol."},{"key":"10.1016\/j.virol.2006.04.003_bib12","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1073\/pnas.1834270100","article-title":"DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus","volume":"100","author":"Hall","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2006.04.003_bib13","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1128\/JVI.77.21.11436-11447.2003","article-title":"Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development","volume":"77","author":"Huang","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0264-410X(00)00191-2","article-title":"Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus: Poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans","volume":"19","author":"Kanesa","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2006.04.003_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0264-410X(97)00215-6","article-title":"Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice","volume":"15","author":"Kochel","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2006.04.003_bib16","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1016\/S0264-410X(00)00105-5","article-title":"A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys","volume":"18","author":"Kochel","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2006.04.003_bib17","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1073\/pnas.0307145101","article-title":"Mimicking live flavivirus immunization with a noninfectious RNA vaccine","volume":"101","author":"Kofler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2006.04.003_bib18","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0264-410X(01)00446-7","article-title":"Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine","volume":"20","author":"Konishi","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2006.04.003_bib19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0042-6822(92)91233-K","article-title":"A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine","volume":"190","author":"Konishi","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.04.003_bib20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0042-6822(92)90526-U","article-title":"Mice immunized with a subviral particle containing the Japanese encephalitis virus prM\/M and E proteins are protected from lethal JEV infection","volume":"188","author":"Konishi","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.04.003_bib21","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0264-410X(99)00376-X","article-title":"A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice","volume":"18","author":"Konishi","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2006.04.003_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/viro.1999.0142","article-title":"Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine","volume":"268","author":"Konishi","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.04.003_bib23","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/JVI.75.5.2204-2212.2001","article-title":"Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles","volume":"75","author":"Konishi","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib24","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1128\/jvi.64.6.3001-3011.1990","article-title":"Mutations which alter the level or structure of nsP4 can affect the efficiency of Sindbis virus replication in a host-dependent manner","volume":"64","author":"Lemm","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib25","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/jvi.65.8.4107-4113.1991","article-title":"In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6000-molecular-weight membrane protein modulates virus release","volume":"65","author":"Liljestrom","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib26","first-page":"991","article-title":"Flaviviridae: the viruses and their replication","volume":"Vol. 1","author":"Lindenbach","year":"2001"},{"key":"10.1016\/j.virol.2006.04.003_bib27","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1128\/JVI.76.11.5480-5491.2002","article-title":"Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum","volume":"76","author":"Lorenz","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0042-6822(91)90034-9","article-title":"Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection","volume":"180","author":"Mason","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.04.003_bib29","first-page":"221","article-title":"Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge","author":"Minke","year":"2004","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-1702(01)00371-9","article-title":"A \u2018minimal\u2019 approach in design of flavivirus infectious DNA","volume":"81","author":"Mishin","year":"2001","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2006.04.003_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.1991.45.1","article-title":"Yellow fever: Victor, Victoria? Conqueror, conquest? Epidemics and research in the last forty years and prospects for the future","volume":"45","author":"Monath","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2006.04.003_bib32","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","article-title":"Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections","volume":"20","author":"Monath","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2006.04.003_bib33","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1128\/JVI.79.12.7597-7608.2005","article-title":"Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in mammalian cells","volume":"79","author":"Petrakova","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/BF01718332","article-title":"Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus","volume":"141","author":"Phillpotts","year":"1996","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0042-6822(92)90317-I","article-title":"Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis","volume":"187","author":"Pincus","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.04.003_bib36","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1073\/pnas.022652799","article-title":"West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy","volume":"99","author":"Pletnev","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2006.04.003_bib38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1006\/viro.1995.1516","article-title":"Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection","volume":"212","author":"Pugachev","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.04.003_bib37","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/JVI.78.2.1032-1038.2004","article-title":"High fidelity of yellow fever virus RNA polymerase","volume":"78","author":"Pugachev","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib39","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1086\/425933","article-title":"Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells","volume":"190","author":"Qiao","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2006.04.003_bib40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.virol.2004.10.046","article-title":"Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action","volume":"331","author":"Rossi","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.04.003_bib41","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/jvi.70.7.4549-4557.1996","article-title":"Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions","volume":"70","author":"Schalich","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib42","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1128\/jvi.71.12.9563-9569.1997","article-title":"Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge","volume":"71","author":"Schmaljohn","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib43","doi-asserted-by":"crossref","first-page":"11605","DOI":"10.1128\/JVI.78.21.11605-11614.2004","article-title":"Trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors","volume":"78","author":"Scholle","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.003_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2005.09.010","article-title":"The efficient packaging of Venezuelan equine encephalitis virus-specific RNAs into viral particles is determined by nsP1\u20133 synthesis","volume":"344","author":"Volkova","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.04.003_bib45","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3201\/eid0704.017420","article-title":"West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis","volume":"7","author":"Xiao","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2006.04.003_bib46","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1128\/jvi.68.9.5765-5771.1994","article-title":"Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study","volume":"68","author":"Yamshchikov","year":"1994","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682206002376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682206002376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:43:28Z","timestamp":1758584608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682206002376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0042682206002376"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2006.04.003","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Production and characterization of vaccines based on flaviviruses defective in replication","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2006.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}